AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...

More than 110,000 North Carolinians are projected to benefit from a $2,000 annual cap on out-of-pocket costs for covered prescription drugs for Medicare Part D participants.

Switching brands of levothyroxine or changing to a generic may affect your symptoms or side effects. This is why it is important to make sure your pharmacist fills your prescription with medication ...

From cutting drug costs to reducing overdose deaths, the outgoing president has improved the nation’s health.

A growing number of older adults are showing interest in “deprescribing,” a process where people reduce or stop taking ...

Pharmacy benefit managers (PBMs) “invent all these special categories,” Cuban told Fortune’s Andrew Nusca. “They’re just ...